Related Experiment Video

Updated: Oct 30, 2025

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

1.9K

Loss-of-Function Mutations in TRAF7 and KLF4 Cooperatively Activate RAS-Like GTPase Signaling and Promote Meningioma

Paul Najm1,2, Peihua Zhao1,2, Mikhail Steklov1,2

  • 1VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.

Cancer Research
|July 3, 2021
PubMed

Insights

TRAF7 mutations in meningioma disrupt proteostasis, altering cell growth. Cooperative interactions with KLF4 mutations drive tumor development, offering new therapeutic targets for brain tumors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Meningiomas are common benign brain tumors.
  • TRAF7 mutations are found in 25% of meningiomas, often co-occurring with KLF4 mutations.
  • The functional relationship between TRAF7 and KLF4 mutations in meningioma pathogenesis is not well understood.

Purpose of the Study:

  • To elucidate the cooperative interactions between TRAF7 and KLF4 in meningioma development using an in vitro model.
  • To identify the molecular mechanisms by which TRAF7 mutations contribute to meningioma formation.
  • To investigate the role of TRAF7 as a proteostatic regulator in meningeal cells.

Main Methods:

  • Generation of an in vitro meningioma model from primary meningeal cells.
  • Integration of TRAF7-driven ubiquitinome, proteome, and interactome data.
  • Analysis of TRAF7 mutations' impact on catalytic activity and RAS GTPase interactions.
  • Assessment of actin dynamics, anchorage-independent growth, and signaling pathway activation (RAS/MAPK, Semaphorin).

Main Results:

  • TRAF7 acts as a proteostatic regulator of RAS-related small GTPases.
  • Meningioma-associated TRAF7 mutations impair its function, leading to altered actin dynamics and anchorage-independent growth via CDC42 and RAS signaling.
  • TRAF7 deficiency activates the RAS/MAPK pathway, promoting KLF4-dependent transcription and upregulation of the tumor-suppressive Semaphorin pathway.
  • KLF4 loss of function exacerbates mutant TRAF7-induced cell transformation by disrupting a negative feedback loop.

Conclusions:

  • This study reveals critical mechanistic insights into meningioma development driven by TRAF7 and KLF4.
  • The identified molecular cross-talk between TRAF7 and KLF4 provides a foundation for novel therapeutic strategies targeting meningioma.
  • Understanding TRAF7's role in proteostasis and its interaction with KLF4 opens new avenues for treating these brain tumors.

More Related Videos

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

6.3K
Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice10:13

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Published on: August 12, 2014

13.6K

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.6K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.5K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.3K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.5K